baber/WOPTO huggingface dataset:
Patent AU-619336-B2 (AU)
Title: Fe-Mn-Al-C alloys and their treatment
Inventor: WAN CHI-MEEN
IPC: C23F1/30
Filed: 1989-07-06
Granted: 1992-01-23
Abstract: This application is a continuation-in-part of application Ser. No. 07/218695, filed Aug. 8, 1988. This invention describes a series of Fe-Mn-Al-C based corrosion resistance alloys. It also describes how to obtain such alloys which has comparable good corrosion resistance in many environments to conventional stainless steel as 304 and 430. The correlation of chemical compositions among the manganese, aluminum, carbon and other minor elements ae discussed. Therefore they are made to be practical and more definitive. According to more advanced understanding in overall of the Fe-Mn-Al-C based alloys that are included in this invention have to be surface treated and/or pickled, passivated by the methods included in this invention. After the surface treatments, the final products will have an obviously comparable depleted manganese and/or higher chromium on the alloy surface and will have better corrosion resistance than the conventional Fe-Mn-Al-C and Fe-Mn-Al-C-Cr based alloys. In addition, the manufacture and fabrication processes for the present designed Fe-Mn-Al-C based alloys also include the meltings, mixings, ingot castings, hot workings, cold workings, heat treatments and surface treatments.
Patent AU-691707-B2 (AU)
Title: Oral immunization with transgenic plants
Inventor: ARNTZEN CHARLES J
IPC: C12R1/91
Filed: 1995-10-24
Granted: 1998-05-21
Abstract: The oral vaccines and oral vaccine adjuvants of the present invention are produced in transgenic plants and then administered through the consumption of the transgenic plant. DNA sequences both natural and synthetic encoding for the expression of immunogenic agents which are capable of causing an immune response in animals when fed in edible plants, plant tissues, or derived plant materials are constructed and plants transformed for stable or transient expression in plant cells. The present invention provides the first known functional method for immunizing animals via transgenic plants, where the plants express bacterial antigens that act as both immunogens and adjuvants when the transgenic plant material expressing the antigens is fed to animals.
Patent AU-731946-B2 (AU)
Title: Local anesthetic for external use
Inventor: INAGI TOSHIO
IPC: A61K47/12
Filed: 1997-10-06
Granted: 2001-04-05
Abstract: A local anesthetic for external use is prepared by blending a) an active ingredient selected from lidocaine, prilocaine, and pharmaceutically acceptable salts thereof; b) a percutaneous absorption accelerator, c) ethanol and/or isopropyl alcohol, and d) water, such that the blending ratio of ethanol and/or isopropyl alcohol to water is 0.5 to 1.2 by weight, and the pH is 6.0 to 8.5.
Patent AU-601357-B2 (AU)
Title: Method and apparatus for immunoassays
Inventor: VALKIRS GUNARS EDWIN
IPC: G01N33/50
Filed: 1985-05-13
Granted: 1990-09-13
Abstract: Disclosed herein is an apparatus and process for conducting ligand receptor assays. The apparatus comprises a first member which is a membrane or a filter to which is bound a receptor for the ligand or which is capable of extracting cells carrying the ligand from a fluid sample. The apparatus further comprises a second member which is composed of absorbent material which acts when in contact with the first member to induce flow through the first member when a fluid sample is added to it. The apparatus is used to conduct assays by applying a sample to the upper surface of the first member to bind ligand in the sample by means of receptor fixed to the first member or, in certain cases, by extracting cellular material which has ligand associated with it. Addition of the sample is typically followed by addition of labeled antibody against the antigen being assayed followed by a washing step to remove unbound labeled receptor. The presence of labeled antibody on the first member after washing is indicative of the presence of the antigen in the sample being assayed. In a preferred embodiment of the invention, the ligand is an antigen and the receptor is an antibody.
Patent AU-631382-B2 (AU)
Title: An electric connector terminal, primarily a so-called isdn-plug, and a method of manufacturing contact strips therefor
IPC: H01R13/33
Filed: 1989-10-17
Granted: 1992-11-26
Abstract: PCT No. PCT/DK89/00243 Sec. 371 Date Apr. 17, 1991 Sec. 102(e) Date Apr. 17, 1991 PCT Filed Oct. 17, 1989 PCT Pub. No. WO90/04863 PCT Pub. Date May 3, 1990.In certain connector plugs use is made of contact strips (13) mounted next to each other such that at one end they form exposed contact springs (8) while at their other ends they have a loop portion (14) provided with a V- of U-shaped recess (16) for connection with a connector wire. The dimensions are rather narrow, and there is hardly room for two such recesses in each loop portion. However, there is an expressed demand for connecting two wires to some of the contact strips, and according to the invention this is made possible by shaping each strip (13) with two loops (14) mutually spaced in the longitudinal direction of the strip, where there is better room than in the width or height direction. With conventional shaping technique it is difficult to provide two loops (14) on one contact strip (13), but the invention comprises a method, which makes this possible, viz. by arranging for an active feeding of strip material to the loop areas from both sides of each of these.
Patent AU-773957-B2 (AU)
Title: Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction
Inventor: GEORGES ELIAS
IPC: C07K7/00
Filed: 2000-05-12
Granted: 2004-06-10
Abstract: The invention relates to protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction. Using overlapping hexapeptides that encode for the entire amino acid sequences of the linker domains of human P-glycoprotein gene 1 and 3 (HP-gp1 and HP-gp3), a direct and specific binding between HP-gp1 and 3 linker domains and intracellular proteins was demonstrated. Three different stretches (<SUP>617</SUP>EKGIYFKLVTM<SUP>627</SUP>, (SEQ ID NO: 1) <SUP>658</SUP>SRSSLIRKRSTRRSVRGSQA<SUP>677 </SUP>(SEQ ID NO: 2) and <SUP>694</SUP>PVSFWRIMKLNLT<SUP>706 </SUP>(SEQ ID NO: 3) for HP-gp1 and <SUP>618</SUP>LMKKEGVYFKLVNM<SUP>631 </SUP>(SEQ ID NO: 4), <SUP>648</SUP>KAATRMAPNGWKSRLFRHSTQKNLKNS<SUP>674 </SUP>(SEQ ID NO: 5), and <SUP>695</SUP>PVSFLKVLKLNKT<SUP>707 </SUP>(SEQ ID NO: 6) for HP-gp3) in linker domains bound to proteins with apparent molecular masses of ~80 kDa, 57 kDa and 30 kDa. The binding of the 57 kDa protein was further characterized. Purification and partial N-terminal amino acid sequencing of the 57 kDa protein showed that it encodes the N-terminal amino acids of alpha and beta-tubulins. The method of the present invention was further validated with Annexin. The present invention thus demonstrates a novel concept whereby the interactions between two proteins are mediated by strings of few amino acids with high and repulsive binding energies, enabling the identification of high affinity binding sites between any interacting proteins.
Patent AU-707418-B2 (AU)
Title: Improved methods and instrumentation for the surgical correction of human thoracic and lumbar spinal disease from the lateral aspect of the spine
Inventor: MICHELSON GARY KARLIN
IPC: A61F2/46
Filed: 1996-02-26
Granted: 1999-07-08
Abstract: An improved method and instrumentation for performing spinal surgery, including discectomy, interbody fusion and rigid internal fixation of the spine, from the lateral aspect of the spine is disclosed. The surgical procedure can be performed through a very small incision. The instrumentation of the present invention, all of which is inserted from a lateral position into the spine in the preferred embodiment, comprises a guide pin, a distractor, an extended outer sleeve, an inner sleeve, an adjustable drill and an implant driver. The distractor of the present invention is driven into the disc for spacing apart and realigning the adjacent vertebrae. It further functions as an alignment rod for inserting the extended outer sleeve which is a hollow tubular member capable of maintaining said spacing and alignment of two adjacent vertebrae and defines a protected space through which subsequent instruments which may include, but are not limited to, a drill and a diameter reducing inner sleeve may be passed, as well as a spinal implant. The remainder of the surgical procedure consisting of the removal of spinal material across the disc, fusion, and rigid internal stabilization via the implant may all be performed via the closed space within the extended outer sleeve. <IMAGE>
Patent AU-731819-B2 (AU)
Title: Benzamidine derivatives
Inventor: TAKAYANAGI MASARU
IPC: C07D213/56
Filed: 1998-01-19
Granted: 2001-04-05
Abstract: Benzamidine derivatives of the following formulae or analogs thereof, i. e., pharmaceutically acceptable salts thereof, are provided. These compounds or salts thereof have a blood-coagulation inhibiting effect based on an excellent effect of inhibiting the action of activated blood coagulation factor X, and they are useful as anticoagulants. <CHEM>
Patent AU-677279-B2 (AU)
Title: Application of carbamazepine and oxcarbazepine in the treatment of Parkinson's disease and Parkinsonian syndromes
Inventor: BOIREAU ALAIN
IPC: A61K31/425
Filed: 1994-01-03
Granted: 1997-04-17
Abstract: PCT No. PCT/FR94/00003 Sec. 371 Date Jun. 6, 1995 Sec. 102(e) Date Jun. 6, 1995 PCT Filed Jan. 3, 1994 PCT Pub. No. WO94/15601 PCT Pub. Date Jul. 21, 1994This invention relates to an application of riluzole or the pharmaceutically acceptable salts in the preparation of drugs for the treatment of Parkinson's disease and parkinsonian syndromes.
Patent AU-689459-B2 (AU)
Title: Process for the preparation of aminotriazine derivatives
Inventor: RAPOLD THOMAS
IPC: C07D253/06
Filed: 1994-03-29
Granted: 1998-04-02
Abstract: The present invention relates to a process for the preparation of aminotriazine derivatives of the formula I <CHEM>  by the solvolysis of compounds of the formula II <CHEM> in the presence of gaseous hydrogen chloride in an alcoholic medium.   The compounds of formula I are useful as intermediates in the manufacture of insecticides.
Patent AU-740081-B2 (AU)
Title: Method for producing card-shaped data carriers
Inventor: BLOME RAINER
IPC: B42D15/00
Filed: 1998-02-11
Granted: 2001-11-01
Abstract: The invention relates to a method and apparatus for producing card-shaped data carriers. The method has at least one production step requiring a data carrier of a defined type or quality or in a defined position and/or changing the data carrier in irreversible fashion or in a fashion which can be reversed only by additional expense. The data carrier is optically tested before or after said production step, and the further processing of the data carrier controlled depending on the result of said test.
Patent AU-760884-B2 (AU)
Title: Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity
Inventor: SCHICKANEDER HELMUT
IPC: C07H17/08
Filed: 1999-10-15
Granted: 2003-05-22
Abstract: A pharmaceutical with an enhanced pharmaceutical profile comprises a mucolytic and an antibiotic in which the mucolytic is present in an amount of greater than one molar equivalent of the antibiotic. The antibiotic may be selected from Erythromycin, Roxithromycin, Clarithromycin, Azithromycin, Dirithromycin; and pharmaceutically acceptable salts or esters thereof. The mucolytic is a mucolytically active thiol, especially N-acetylcysteine, mercaptoethanesulfonic acid, tiopronin or methylcysteine. The adducts can be isolated via a simple and efficient process.
Patent AU-641677-B2 (AU)
Title: Particulate contrast media
Inventor: GUNDERSEN HELGE GUTTORM
IPC: A61K49/18
Filed: 1990-07-19
Granted: 1993-09-30
Abstract: There is provided a magnetic resonance contrast medium comprising magnetically responsive particles and a physiologically tolerable osmoactive agent.
Patent AU-605127-B2 (AU)
Title: Carbacyclins
Inventor: VORBRUGGEN HELMUT
IPC: C07C227/00
Filed: 1986-11-28
Granted: 1991-01-10
Abstract: Carbacycline derivatives of general formula (I), in which Y1 is the residue of Formula (II), R9 is the residue -(CH2)m-R6 or the residue -(CH2)m-o-[Z1-(CH2)m-p]x-[Z2-(CH2)m-q]y-R6, m = 2-20; o, p and q <= 19; x, y = 0, 1 or 2; Z1 is a cis-CH=CH-group, a trans-CH=CH-group or a -C=C-group, whereby each of these groups must be separated at least by one methyl group from the C-9 carbon atom of the carbacycline bi-cycle; Z2 is oxygen, sulphur, an NH or an N-methyl group, R6 is amino, methylamino, hydroxy, carboxy or mercapto; and process for their manufacture and their use as medicaments.
Patent AU-677067-B2 (AU)
Title: Magnesium salt of 3-isopropyl-2,1,3-benzothiadiazin-4-one- 2,2-dioxide, method of preparing it and its use in the control of undesirable plant growth
Inventor: JAEGER KARL-FRIEDRICH
IPC: A01N43/88
Filed: 1994-05-02
Granted: 1997-04-10
Abstract: PCT No. PCT/EP94/01391 Sec. 371 Date Oct. 26, 1995 Sec. 102(e) Date Oct. 26, 1995 PCT Filed May 2, 1994 PCT Pub. No. WO94/26727 PCT Pub. Date Nov. 24, 1994Solid, non-hygroscopic magnesium salt of 3-isopropyl-2,1,3-benzothiadiazin-4-ones 2,2-dioxide (I), processes for its preparation, solid formulations, in particular granules, which contain this salt, and the use thereof for controlling undesirable plant growth.
Patent AU-740367-B2 (AU)
Title: Modular humeral prosthesis
Inventor: DEWS PAUL M
IPC: A61F2/30
Filed: 1998-04-03
Granted: 2001-11-01
Abstract: A modular humeral prosthesis for replacement of the humeral head of a humerus. The prosthesis generally comprises a stem to be fitted to a resected humerus; a head sized and configured to approximate the humeral head; and an intermediate connecting member for connecting the stem to the head. A first engagement/mounting portion is provided on the intermediate connecting member for mounting the intermediate connecting member on the stem, and a second engagement/mounting portion is provided on the intermediate connecting member for mounting the head on the intermediate connecting member. The first engagement/mounting portion has an axis about which the intermediate connecting member can be rotated through 360° relative to the stem and thereafter secured at a selected relative orientation. The second engagement/mounting portion has an axis about which the head can be rotated through 360° relative to the intermediate connecting member and thereafter secured at a selected relative rotation. The axis of rotation of the first and second engagement/mounting portions are not coincident, whereby the first and second engagement/mounting portions allow the head to be given a desired offset relative to the stem. Also disclosed is a modular humeral prosthesis kit comprising a variety of different intermediate connecting members that may be selected to fit the prosthesis to the patient, and a method of replacing a humeral head in a patient.
Patent AU-633699-B2 (AU)
Title: Method for purifying somatotropin monomers
IPC: C12P21/00
Filed: 1991-02-27
Granted: 1993-02-04
Abstract: A method for purifying and recovering biologically active somatotropin monomers from refold solution following the solubilization and naturation of refractile bodies of host cells produced by recombinant DNA methodology. The purification process is based on the discovery that somatotropin monomers and somatotropin oligomers having overlapping isoelectric points may nevertheless be separated by selective precipitation over a narrow pH range. Host cell residues including proteins, pyrogens and other impurities present in the refold solution are effectively removed in the process. The purified somatotropin monomers recovered from solution after removing precipitated solids are suitable for parenteral application to target animals without further purification.
Patent AU-632214-B2 (AU)
Title: Carrier stock with tear-open tabs
IPC: B65D71/50
Filed: 1991-04-11
Granted: 1992-12-17
Abstract: Carrier stock (10) is formed from a single sheet of resilient polymeric material, such as low density polyethylene, for machine application to substantially identical containers (12). The stock (10) is severable to form individual carriers (20) with container-receiving apertures (14), as defined by band segments, which include outer segments (22) formed with tear-open tabs (30). Each tab (30) and preferably the outer segment (22) have multiple slits (32,40,50,52), which are arranged to define tearable bridges (42,54,56,58) that can be easily torn by a user pulling on such tab (30), whereby the outer segment formed with such a tab (30) can be easily severed to release a container from the aperture (14) bounded partly by such a segment (22). <IMAGE>
Patent AU-594177-B2 (AU)
Title: A credit card verifier
Inventor: MCGUIRE JOHN FINBARR
IPC: G07F7/08
Filed: 1987-07-27
Granted: 1990-03-01
Abstract: A point-of-sale credit card verifier (1) for checking the validity of cards, such as credit cards, comprises means for non-destructively storing information (3) on invalid credit cards for comparison with information which is read from a card presented for use. The information on invalid credit cards is transmitted by signals embedded in a VHF stereo radio broadcast from a broadcast station which is received by a VHF receiver/demodulator (10). A credit card sensor (4) and control maintains the verifier switched off unless a credit card is to be read. The verifier is switched on when information is about to be broadcast from a broadcast station. The verifier operates quickly and independently of telecommunications networks.
Patent AU-778901-B2 (AU)
Title: Indexing system
Inventor: ERISALU ENN
IPC: B42F21/02
Filed: 2000-10-12
Granted: 2004-12-23
Abstract: An index system using single axis or multiple axes with single and multiple leaves turning around this axis (axes). All leaves or groups of leaves present an exposed marginal portion obtained by relative extension of leaves and/or partial removal of a portion of the marginal portion (s), which provides an overview of the content, which is indexed in groups and subgroups. Use is made of brief descriptions, capital letters, numbers, arrows and distinctive background color for facilitating the use of the index system.
Patent AU-756136-B2 (AU)
Title: Microdose therapy
Inventor: ADAMS MICHAEL A
IPC: A61P15/10
Filed: 1998-06-22
Granted: 2003-01-02
Abstract: Methods for treating vascular conditions associated with localized imbalance in vascular tone, which are hypothesized to be largely due to elevated endothelin (ET) are provided. The methods involve administration of nitric oxide (NO), agents which are able to provide NO, such as NO donors, agents which activate guanyl cyclase, such as YC-1, or agents which prolong the actions of endogenous NO or cyclic guanosine monophosphate (cGMP; a 2nd messenger molecule), such as phosphodiesterase (PDE) inhibitors. According to the invention, such agents are administered in minimal doses or microdoses by any route known in the art, so as to provide dosages which are about one half to about one twentieth (½ to 1/20) of those known to induce vasodilation in "normal" circulations. The low doses of these agents effectively alleviate vascular conditions associated with a reduction in NO production or an attenuation of NO effect, by restoring balance in vascular tone while exerting almost no systemic effect in normal vasculature.
Patent AU-604814-B2 (AU)
Title: Amycin and its derivatives, a process for their preparation, and their use
Inventor: HAMMANN PETER
IPC: A01N63/02
Filed: 1987-12-23
Granted: 1991-01-03
Abstract: Streptomyces parvullus, DSM 3816, produces on aerobic fermentation new antibiotics which are distinguished by antimicrobial activity even after derivatization.
Patent AU-655595-B2 (AU)
Title: Benzimidazole derivatives, process for their preparation and application
Inventor: WHITTAKER MARK
IPC: A61K31/435
Filed: 1991-08-15
Granted: 1995-01-05
Abstract: Compounds of general formula I;   <IMAGE> I  wherein: A1 is =N-, =CH- or =CR1-; A2 is =N-, =CH- or =CR2-; provided that, when one of A1 and A2 is a nitrogen atom, the other of A1 and A2 is other than a nitrogen atom; wherein the other variables are as defined in the specification and their pharmaceutically and veterinarily acceptable acid addition salts and hydrates are antagonists of platelet activating factor (PAF) and as such are useful in the treatment or amelioration of various diseases or disorders mediated by PAF.
Patent AU-730734-B2 (AU)
Title: Safety switching system for clamping devices for pipes
Inventor: JANSCH MANFRED
IPC: E21B19/07
Filed: 1998-06-20
Granted: 2001-03-15
Abstract: The invention relates to a safety switching system for a clamping device used for holding and/or lowering and raising a line of pipes (13) lining a borehole. Said safety switching system is mounted inside the clamping device, where it is protected from external mechanical influences. To this end, a shift cam (18) for a safety shift valve (1, 2) is fastened to the clamping wedge support (14a, 14b) of the clamping device. This valve is mounted on the base (10) of the clamping device, and cooperates with the shift cam when the clamping wedges (12a, 12b) adopt their prescribed clamping position on the line of pipes.
Patent AU-661826-B2 (AU)
Title: Laundry detergent compositions containing crystalling/layeredsilicates
Inventor: PRETTY ALASTAIR JOHN
IPC: C11D3/37
Filed: 1991-08-05
Granted: 1995-08-10
Abstract: Particulate laundry detergent compositions are disclosed incorporating 5 % to 50 % of a surfactant, from 10 % to 95 % of a three-component non-phosphorus builder system comprising a mixture of a sodium aluminosilicate zeolite, a water-soluble monomeric or oligomeric carboxylate chelating agent and a crystalline layered sodium silicate, and from 0 % to 40 % of non-surfactant, non-builder detergent ingredients. The crystalline layered silicate is of composition NaMSixO2x+1.yH2O where M is sodium or hydrogen, x is a number from 1.9 to 4 and y is a number from 0 to 20. Preferably M is sodium, x is 2 and y is O.
Patent AU-681996-B2 (AU)
Title: Shaving system
Inventor: ROGERS BRIAN A
IPC: B26B21/44
Filed: 1991-09-20
Granted: 1997-09-18
Abstract: A shaving unit comprises at least one blade and a shaving composite that has a surface for engaging the user's skin adjacent the blade edge. The shaving unit may be of a disposable cartridge type adapted for coupling to and uncoupling from a razor handle or may be integral with a handle so that the complete razor is discarded as a unit when the blade or blades become dulled. The blade edge (or edges) cooperate with skin engaging surfaces to define shaving geometry. The shaving aid composite is a mixture of water insoluble matrix material, an effective amount of shaving aid material, and a water soluble low molecular weight release enhancing agent that enhances the releasability of the shaving aid material from the matrix material.
Patent AU-663851-B2 (AU)
Title: Polyhydroxy fatty acid amide surfactants to enhance enzyme performance
Inventor: MAO MARK HSIANG-KUEN
IPC: C11D1/52
Filed: 1991-09-25
Granted: 1995-10-26
Abstract: Disclosed is an improved detergent composition comprising one or more anionic surfactants, nonionic surfactants, or mixtures thereof, and detersive enzymes, the improvement which comprises incorporating into said composition an enzyme performance-enhancing amount of a polyhydroxy fatty acid amide material of formula (I), wherein R<1> is H1, C1-C4 hydrocarbyl, 2-hydroxy ethyl, 2-hydroxy propyl, or a mixture thereof, R2 is C5-C31 hydrocarbyl, and Z is a polyhydroxyhydrocarbyl having a linear hydrocarbyl chain with at least three hydroxyls directly connected to said chain, or an alkoxylated derivative thereof.